Natalia Fintelman‐Rodrigues
Fundação Oswaldo Cruz(BR)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Influenza Virus Research Studies, Mosquito-borne diseases and control, Animal Virus Infections Studies
Most-Cited Works
- → Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators(2020)300 cited
- → SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes(2021)272 cited
- → The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication(2017)237 cited
- → Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production(2020)138 cited
- → In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19(2021)99 cited
- → Copy-Number Gains of HUWE1 Due to Replication- and Recombination-Based Rearrangements(2012)87 cited
- → Repurposing the Ebola and Marburg Virus Inhibitors Tilorone, Quinacrine, and Pyronaridine: In Vitro Activity against SARS-CoV-2 and Potential Mechanisms(2021)74 cited
- → Combination of antiviral drugs inhibits SARS-CoV-2 polymerase and exonuclease and demonstrates COVID-19 therapeutic potential in viral cell culture(2022)70 cited
- → Atazanavir inhibits SARS-CoV-2 replication and pro-inflammatory cytokine production(2020)69 cited
- → KDM5C mutational screening among males with intellectual disability suggestive of X-Linked inheritance and review of the literature(2014)65 cited